When a reporter for the New York Times set out to test three genetic tests, she received extremely varied results.
This isn’t the first time that journalists have evaluated these tests, and it won’t be the last. Academics like Stanford’s Hank Greely have devoted years of research to exploring the ethical and legal implications of the new biomedicine technologies, particularly those related to genetics.
How should we interpret damning reports like this? Should we avoid genetic testing altogether? This is still such a nascent sector, so is it better to wait until the technology evolves? I asked Greeley, a genetics professor and the director at the center for law and biosciences at Stanford University, to weigh in.
Read the full, original story: Genetics prof: Why I won’t waste my money on a DNA test in 2014
